Brief: Opaleye Management Reports 10.69% Stake In Tela Bio As Of June 7 - SEC Filing
10/06/2022 22:08
June 10 (Reuters) - TELA Bio Inc TELA.O :
* OPALEYE MANAGEMENT REPORTS 10.69% STAKE IN TELA BIO, INC
AS OF
JUNE 7, 2022 - SEC FILING
Further company coverage: TELA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TELA Bio
See all newsBrief: Tela Bio - Receives FDA 510(K) Clearance For Liora Monofilament Scaffold For Soft Tissue Reinforcement
Tela Bio Inc Reports Results For The Quarter Ended June 30: Earnings Summary
TELA Bio Q2 revenue falls on lower OviTex PRS volumes, withdraws outlook
Brief: TELA Bio Q2 Revenue USD 19.291 Million Vs. IBES Estimate USD 20 Million
Tela Bio Inc Expected To Post A Loss Of 18 Cents A Share: Earnings Preview